The pristane-primed arthritogenic T cells which are used to transfer arthritis could secrete IFN-γ and TNF-α with Con A stimulation in vitro, and pretreatment of recipient rats with either anti-IFN-γ or a recombinant TNF-α receptor before transfer, ameliorated arthritis development [38]. The gene discussed is IFNG; the disease is Arthritis.